BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Staging
143 results:

  • 1. Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.
    Meng X; Hao F; Wang N; Qin P; Ju Z; Sun D
    BMC Med Res Methodol; 2024 Apr; 24(1):90. PubMed ID: 38637725
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Differential response to neoadjuvant endocrine therapy for Black/African American and White women in NCDB.
    Jones V; Schroeder MC; Roberson ML; De Andrade J; Lizarraga IM
    Breast Cancer Res Treat; 2024 Jan; 203(1):125-134. PubMed ID: 37740855
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative breast cancer Patients.
    Vasilyeva E; Hamm J; Nichol A; Isaac KV; Bazzarelli A; Brown C; Lohrisch C; McKevitt E
    Ann Surg Oncol; 2023 Oct; 30(11):6413-6424. PubMed ID: 37358683
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of Characteristics of breast cancer Detected through Different Imaging Modalities in a Large Cohort of Hong Kong Chinese Women: Implication of Imaging Choice on Upcoming Local Screening Program.
    Chan YS; Hung WK; Yuen LW; Chan HYY; Chu CWW; Cheung PSY
    Breast J; 2022; 2022():3882936. PubMed ID: 37228360
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. breast cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes.
    Ditsatham C; Sripan P; Chaiwun B; Klunklin P; Tharavichitkul E; Chakrabandhu S; Muangwong P; Chitapanarux I
    BMC Cancer; 2022 Nov; 22(1):1147. PubMed ID: 36348356
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Axillary staging Is Not Justified in Postmenopausal Clinically Node-Negative Women Based on Nodal Disease Burden.
    Lee MK; Montagna G; Pilewskie ML; Sevilimedu V; Morrow M
    Ann Surg Oncol; 2023 Jan; 30(1):92-97. PubMed ID: 35876927
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence.
    Haarsma R; van Loevezijn AA; Donswijk ML; Scholten AN; Vrancken Peeters MTFD; van Duijnhoven FH
    Breast Cancer Res Treat; 2022 Aug; 194(3):617-627. PubMed ID: 35727380
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Incidence of Occult breast cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
    Wong SM; Ferroum A; Apostolova C; Alhassan B; Prakash I; Basik M; Boileau JF; Meterissian S; Aleynikova O; Wong N; Foulkes WD
    Ann Surg Oncol; 2022 Oct; 29(11):6660-6668. PubMed ID: 35616744
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Pretreatment evaluation of
    Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
    [No Abstract]    [Full Text] [Related]  

  • 10. pN0(i+) and pN1mi breast cancer: Treatment and Outcomes in Comparison With pN0 and pN1a in the Modern Era.
    Dosani M; Hamilton SN; Gondara L; Speers C; Diocee RM; Nichol A; Lohrisch C; Truong P
    Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):805-815. PubMed ID: 35385784
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database.
    Wang W; Shen Z; Zhang J; Chen H; Deng X; Peng C; Xie J; Xu Z; Shen B
    Ann Surg Oncol; 2022 Mar; 29(3):1533-1539. PubMed ID: 34622372
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Trends and Outcomes Associated With Axillary Management of Males With Clinical N0 breast cancer-An NCDB Analysis.
    Carter M; Reyna C; Shaughnessy E; Hanseman D; Meier T; Barrord M; Lewis JD
    J Surg Res; 2021 Dec; 268():97-104. PubMed ID: 34298212
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A multilevel assessment of the social determinants associated with the late stage diagnosis of breast cancer.
    de Oliveira NPD; de Camargo Cancela M; Martins LFL; de Souza DLB
    Sci Rep; 2021 Feb; 11(1):2712. PubMed ID: 33526801
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Delay in surgery is associated with axillary upstaging of clinically node negative breast cancer patients.
    Khader A; Chang SC; Santamaria-Barria J; Garland-Kledzik M; Scholer A; Goldfarb M; Grumley J; Fischer T
    J Surg Oncol; 2021 Mar; 123(4):854-865. PubMed ID: 33333624
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Could lymph node evaluation be eliminated in nearly 50% of women with early stage ER/PR positive breast cancer?
    Ruiz J; Maldonado G; Ablah E; Okut H; Reyes J; Quinn K; Tenofsky PL
    Am J Surg; 2020 Dec; 220(6):1417-1421. PubMed ID: 33097191
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
    Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML
    Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
    Dong Y; Qiu Y; Deng J; Wang W; Sun Z; Wang Z; Zhou Z; Xu H; Liang H
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):515-528. PubMed ID: 31813005
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
    Carrie C; Magné N; Burban-Provost P; Sargos P; Latorzeff I; Lagrange JL; Supiot S; Belkacemi Y; Peiffert D; Allouache N; Dubray BM; Servagi-Vernat S; Suchaud JP; Crehange G; Guerif S; Brihoum M; Barbier N; Graff-Cailleaud P; Ruffion A; Dussart S; Ferlay C; Chabaud S
    Lancet Oncol; 2019 Dec; 20(12):1740-1749. PubMed ID: 31629656
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Stage-Specific Survival Rate of breast cancer Patients in Northern Thailand in Accordance with Two Different staging Systems.
    Chitapanarux I; Sripan P; Somwangprasert A; Charoentum C; Onchan W; Watcharachan K; Wongmaneerung P; Kongmebhol P; Jia-Mahasap B; Huntrakul L
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2699-2706. PubMed ID: 31554366
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Assessing a modified-AJCC TNM staging system in the New South Wales cancer Registry, Australia.
    Lawrance S; Bui C; Mahindra V; Arcorace M; Cooke-Yarborough C
    BMC Cancer; 2019 Aug; 19(1):850. PubMed ID: 31462255
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.